1. Jaffe, Elaine S. 美国 National Cancer Institute 2008美国医学院院士 International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman d..
2. Kojo Seys John,Elenitoba-Johnson 美国 University of Pennsylvania 2023美国医学院院士 International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman d..
3. Anderson, Kenneth C. 美国 Harvard Medical School 2010美国医学院院士 Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy ..
4. 黄晓军 中国 北京大学 2023中国工程院院士 Improved Response Rates with Bortezomib in Relapsed or Refractory Multiple Myeloma: An Observational..
5. 黄晓军 中国 北京大学 2023中国工程院院士 Bortezomib improves progression-free survival in multiple myeloma patients overexpressing preferenti..
6. Zinzani, Pier Luigi 美国 Alma Mater Studiorum Università di Bologna Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-bas..
7. Luca,Arcaini 意大利 University of Pavia Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-bas..
8. Giovanni,Barosi 意大利 San Matteo Policlinic, Pavia Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-bas..
9. David C,Fajgenbaum 美国 University of Pennsylvania A prospective, multicenter study of bortezomib, cyclophosphamide, and dexamethasone in relapsed/refr..
10. Chanan-Khan, Asher A. 美国 Mayo Clinic - Rochester Myelomatous ascites and pleural effusion in relapsed multiple myeloma
11. Evangelos,Terpos 希腊 University of Athens Association Of-308G/A,-238G/A TNF-alpha Polymorphisms with Multiple Myeloma Risk and Survival: A Sys..
12. Meletios Athanasios,Dimopoulos 希腊 National and Kapodistrian University of Athens Association Of-308G/A,-238G/A TNF-alpha Polymorphisms with Multiple Myeloma Risk and Survival: A Sys..
13. 胡豫 中国 华中科技大学 Prognostic nomogram incorporating cytokines for overall survival in patients with newly diagnosed mu..
14. Kalofonos, Haralabos P. 希腊 University of Patras NF-kappa B2 and RELB offer prognostic information in colorectal cancer and NFKB2 rs7897947 represent..
15. Marvin I,Schwarz 美国 University of Colorado Bronchoalveolar lavage as a diagnostic procedure: a review of known cellular and molecular findings ..
16. Edward D,Chan 美国 National Jewish Health Bronchoalveolar lavage as a diagnostic procedure: a review of known cellular and molecular findings ..
17. 陈旻湖 中国 中山大学 主任医师 CYP2C19 polymorphism has no correlation with the efficacy and safety of thalidomide in the treatment..
18. Hutz, Mara Helena 巴西 University of Federal Rio Grande do Sul NR3C1, ABCB1, TNF and CYP2C19 polymorphisms association with the response to the treatment of erythe..
19. Frits,Van Rhee 美国 University of Arkansas International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman d..
20. Angela,Dispenzieri 美国 Mayo Clinic - Rochester International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman d..